Airway cellular response to two different immunosuppressive regimens in lung transplant recipients

D. J. Slebos, G. H. Koëter, H. F. Kauffman, W. van der Bij, E. A. M. Verschuuren, D. S. Postma (Groningen, The Netherlands)

Source: Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. J. Slebos, G. H. Koëter, H. F. Kauffman, W. van der Bij, E. A. M. Verschuuren, D. S. Postma (Groningen, The Netherlands). Airway cellular response to two different immunosuppressive regimens in lung transplant recipients. Eur Respir J 2004; 24: Suppl. 48, 2917

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006

The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

How to use new immunosuppressive drugs in lung transplantation
Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation
Year: 2006

Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Evaluation of the biological effects of atorvastatin in lung transplant recipients
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009


Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004



Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003

Pre-habilitation in lung transplant candidates
Source: Short video discussion 2021
Year: 2021

CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012


Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016


Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011

Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013


Do NHBD and HBD recipients have different airway inflammatory profiles early after LTx?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008


Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001